文献速递免疫规划卫生政策与健康促进

儿科医生对儿童COVID-19疫苗的认知、实践与障碍:加拿大安大略省横断面调查

Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.
PubMed 文献 · Vaccine · 2023-04-03

该研究对加拿大安大略省1313名儿科医生进行在线横断面调查,152名回应(回应率11.6%),调查时间为2022年2月17日至3月17日。92%的儿科医生非常可能推荐5至11岁儿童接种COVID-19疫苗,认为疫苗安全有效,但仍有培训和能力建设空间。

要点

  • 92%的受访儿科医生非常可能推荐5至11岁儿童接种COVID-19疫苗。
  • 多数医生认为5至11岁儿童因Delta或Omicron急性COVID-19重症可能性低。
  • 97%的医生自信能为5至11岁儿童照护者提供疫苗咨询。

核心结论

  • 多数受访儿科医生非常可能推荐5至11岁儿童接种COVID-19疫苗,认为疫苗安全有效,并对该年龄段疫苗咨询有信心,但仍存在进一步培训和能力建设的领域。

研究设计与样本

  • 描述性横断面研究,向加拿大安大略省1313名儿科医生发放在线自填问卷,采用描述性统计及卡方或Fisher精确检验。

主要发现

  • 共152名儿科医生回应,回应率11.6%,调查时间为2022年2月17日至3月17日。
  • 78%为普通儿科医生,22%为儿科亚专科医生;执业年数中位数17年(8-31),女性68%,男性32%。
  • 多数医生认为5至11岁儿童因Delta(66%)或Omicron(80%)急性COVID-19重症可能性低。
  • 92%非常可能推荐5至11岁儿童接种COVID-19疫苗;97%自信能为该年龄段照护者提供疫苗咨询。
  • COVID-19疫苗被认为安全,5至11岁儿童的安全感知高于12至17岁(p < 0.0001);对Delta的感知有效性高于Omicron(p < 0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: SARS-CoV-2 vaccination of all age-eligible populations is an important part of the COVID-19 pandemic response. In Ontario, vaccination coverage in 5-to-11-year-old children has remained lower than in other age groups. We sought to understand pediatricians' perception, practices, and barriers to SARS-CoV-2 vaccination in children, particularly children aged 5-to-11 years, to inform interventions and promote capacity of pediatricians as vaccinators and vaccination promoters. METHODS: This is a descriptive, cross-sectional study consisting of an online self-administered questionnaire distributed to 1,313 pediatricians in Ontario. Descriptive statistics, including Chi-square or Fisher's exact tests, were performed. RESULTS: In total, 152 Pediatricians responded (11.6% response rate), from February 17, 2022 to March 17, 2022. 78% of respondents were general pediatricians and 22% were pediatric subspecialists. Median years of practice was 17 (8-31), with 68% female, 32% male. Most pediatricians thought it was unlikely that children aged 5-to-11 years would become seriously ill from acute COVID-19 caused by Delta (66%) or Omicron (80%). 92% were very likely to recommend the COVID-19 vaccine for children aged 5-to-11 years. COVID-19 vaccine was perceived as safe, with higher safety perception in children aged 5-to-11 compared to 12-to-17 years (p < 0.0001). COVID-19 vaccines were thought to be effective in reducing hospitalization or severe illness, and reducing SARS-CoV-2 infection, with higher perceived effectiveness against Delta compared to Omicron (p < 0.0001). 97% felt confident counselling caregivers of children aged 5-to-11 years on the COVID-19 vaccine. Few pediatricians did not feel confident in accessing resources for health professionals (6%) or for patients/caregivers (12%). CONCLUSIONS: Most surveyed pediatricians were very likely to recommend COVID-19 vaccination for children aged 5-to-11-years, perceived COVID-19 vaccines as safe and effective, and felt confident in their COVID-19 vaccine counselling for children aged 5-to-11 years. However, there remains areas for further training and capacity development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ali Y, Piche-Renaud PP, Karimi-Shahrbabak E, et al. Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada. Vaccine. 2023. PMID: 37045681. doi:10.1016/j.vaccine.2023.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。